Connect with us

Marijuana Movement

Medical Cannabis Sales Can’t Keep Up with Recreational Cannabis Sales in Colorado

Published

on

Medical Cannabis Sales Can’t Keep Up with Recreational Cannabis Sales in Colorado
  • Medical marijuana sales have not surpassed recreational marijuana sales since 2015.
  • Many consumers are opting against registration for a medical card in states where recreational use is legalized.

The legalization of recreational marijuana had a bumpy start in Colorado, as the lack of supply kept the industry from truly flourishing at its greatest capacity. However, in 2018, the recreational market has boomed, bringing in even more revenue than medical marijuana sales, which has established a new milestone in the progressive state.

According to data from the Marijuana Enforcement Division (MED) in Colorado, a total of 147,863 pounds of buds were sold in the medical market last year. In comparison, the recreational cannabis sold amounted to 288,295 pounds of buds, which is about twice the amount of medical cannabis. In 2017, these amounts were 238,149 pounds and 172,994 pounds in the recreational and cannabis markets, respectively. Clearly, the sale of recreational marijuana is surpassing the amount of sales of medical marijuana, increasing the gap between the two revenues by 75% in a matter of a year.

Colorado established itself as the first market for recreational marijuana sales in 2014, and the continual expansion of this market is likely the reason that sales have increased. The last time that the recreational market made lesser profits that medical marijuana was the first year it was available, selling only 38,660 pounds by the end of 2015. Medical marijuana, however, reached 109,578 pounds sold.

The sales equalized in 2016, but the following year, the sales significantly shifted. Recreational marijuana sales took the lead, representing a share of 58% of the market, increasing the 66% by 2018. However, part of the reason that medical marijuana sales may have dwindled could be the registration and renewal fee associated with the medical card, which is fairly high. Recreational use requires no such registration, saving hundreds of dollars a year for regular cannabis users.

The MED report indicated that the primary purchases made by recreational users is edibles, as 86% of all edibles sold came from this side of the market. From July to December 2018, this market had even taken up 75% of the grown cannabis. Interestingly, based on a study on the purchases of both recreational and medical marijuana, the purpose for these sales appears to be the same – reducing pain and handling sleep issues.

The decrease of medical users in recreationally permissive states has decreased across all other states with an adult-use market, and analysts believe that the cause is the same.

Alexander G. Smith is an experienced researcher for both new health topics and science coverage. Being a seasoned Human Resources professional, his content writing skills have sharpened in the areas of workplace and business topics but loves to focus on wellness and natural alternatives here at TOC.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.